Cargando…
Epidemiologie von SARS-CoV-2/COVID 19: Aktueller Stand
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a beta coronavirus, which first appeared in 2019 and rapidly spread causing a worldwide pandemic. Here we present a nonsystematic review of the current knowledge on its epidemiological features. The SARS-CoV‑2 replicates mainly in the u...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594942/ https://www.ncbi.nlm.nih.gov/pubmed/33144889 http://dx.doi.org/10.1007/s11377-020-00479-y |
_version_ | 1783601731853090816 |
---|---|
author | Salzberger, B. Buder, F. Lampl, B. T. Ehrenstein, B. Hitzenbichler, F. Holzmann, T. Schmidt, B. Hanses, F. |
author_facet | Salzberger, B. Buder, F. Lampl, B. T. Ehrenstein, B. Hitzenbichler, F. Holzmann, T. Schmidt, B. Hanses, F. |
author_sort | Salzberger, B. |
collection | PubMed |
description | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a beta coronavirus, which first appeared in 2019 and rapidly spread causing a worldwide pandemic. Here we present a nonsystematic review of the current knowledge on its epidemiological features. The SARS-CoV‑2 replicates mainly in the upper and lower respiratory tract and is mainly transmitted by droplets and aerosols from asymptomatic and symptomatic infected subjects. The estimate for the basic reproduction number (R0) is between 2 and 3 and the median incubation period is 6 days (range 2–14 days). Similar to the related coronaviruses SARS and Middle East respiratory syndrome (MERS), superspreading events play an important role in spreading the disease. The majority of infections run an uncomplicated course but 5–10% of those infected develop pneumonia or a systemic inflammation leading to hospitalization, respiratory and potentially multiorgan failure. The most important risk factors for a complicated disease course are age, hypertension, diabetes, chronic cardiovascular and pulmonary diseases and immunodeficiency. The current infection fatality rate over all age groups is between 0.5% and 1% and the rate rises after the sixth decade of life. Nosocomial transmission and infections in medical personnel have been reported. A drastic reduction of social contacts has been implemented in many countries with outbreaks of SARS-CoV‑2, leading to rapid reductions in R0. Most interventions have used bundles and which of the measures have been more effective is still unknown. Using mathematical models an incidence of 0.4%–1.8% can be estimated for the first wave in Germany. |
format | Online Article Text |
id | pubmed-7594942 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Medizin |
record_format | MEDLINE/PubMed |
spelling | pubmed-75949422020-10-30 Epidemiologie von SARS-CoV-2/COVID 19: Aktueller Stand Salzberger, B. Buder, F. Lampl, B. T. Ehrenstein, B. Hitzenbichler, F. Holzmann, T. Schmidt, B. Hanses, F. Gastroenterologe Schwerpunkt Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a beta coronavirus, which first appeared in 2019 and rapidly spread causing a worldwide pandemic. Here we present a nonsystematic review of the current knowledge on its epidemiological features. The SARS-CoV‑2 replicates mainly in the upper and lower respiratory tract and is mainly transmitted by droplets and aerosols from asymptomatic and symptomatic infected subjects. The estimate for the basic reproduction number (R0) is between 2 and 3 and the median incubation period is 6 days (range 2–14 days). Similar to the related coronaviruses SARS and Middle East respiratory syndrome (MERS), superspreading events play an important role in spreading the disease. The majority of infections run an uncomplicated course but 5–10% of those infected develop pneumonia or a systemic inflammation leading to hospitalization, respiratory and potentially multiorgan failure. The most important risk factors for a complicated disease course are age, hypertension, diabetes, chronic cardiovascular and pulmonary diseases and immunodeficiency. The current infection fatality rate over all age groups is between 0.5% and 1% and the rate rises after the sixth decade of life. Nosocomial transmission and infections in medical personnel have been reported. A drastic reduction of social contacts has been implemented in many countries with outbreaks of SARS-CoV‑2, leading to rapid reductions in R0. Most interventions have used bundles and which of the measures have been more effective is still unknown. Using mathematical models an incidence of 0.4%–1.8% can be estimated for the first wave in Germany. Springer Medizin 2020-10-29 2020 /pmc/articles/PMC7594942/ /pubmed/33144889 http://dx.doi.org/10.1007/s11377-020-00479-y Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Schwerpunkt Salzberger, B. Buder, F. Lampl, B. T. Ehrenstein, B. Hitzenbichler, F. Holzmann, T. Schmidt, B. Hanses, F. Epidemiologie von SARS-CoV-2/COVID 19: Aktueller Stand |
title | Epidemiologie von SARS-CoV-2/COVID 19: Aktueller Stand |
title_full | Epidemiologie von SARS-CoV-2/COVID 19: Aktueller Stand |
title_fullStr | Epidemiologie von SARS-CoV-2/COVID 19: Aktueller Stand |
title_full_unstemmed | Epidemiologie von SARS-CoV-2/COVID 19: Aktueller Stand |
title_short | Epidemiologie von SARS-CoV-2/COVID 19: Aktueller Stand |
title_sort | epidemiologie von sars-cov-2/covid 19: aktueller stand |
topic | Schwerpunkt |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594942/ https://www.ncbi.nlm.nih.gov/pubmed/33144889 http://dx.doi.org/10.1007/s11377-020-00479-y |
work_keys_str_mv | AT salzbergerb epidemiologievonsarscov2covid19aktuellerstand AT buderf epidemiologievonsarscov2covid19aktuellerstand AT lamplbt epidemiologievonsarscov2covid19aktuellerstand AT ehrensteinb epidemiologievonsarscov2covid19aktuellerstand AT hitzenbichlerf epidemiologievonsarscov2covid19aktuellerstand AT holzmannt epidemiologievonsarscov2covid19aktuellerstand AT schmidtb epidemiologievonsarscov2covid19aktuellerstand AT hansesf epidemiologievonsarscov2covid19aktuellerstand |